These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
709 related articles for article (PubMed ID: 4357610)
1. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog. Blonde L; Wehmann RE; Steiner AL J Clin Invest; 1974 Jan; 53(1):163-72. PubMed ID: 4357610 [TBL] [Abstract][Full Text] [Related]
2. Sources of cyclic nucleotides in plasma. Wehmann RE; Blonde L; Steiner AL J Clin Invest; 1974 Jan; 53(1):173-9. PubMed ID: 4357611 [TBL] [Abstract][Full Text] [Related]
3. Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man. Broadus AE; Kaminsky NI; Hardman JG; Sutherland EW; Liddle GW J Clin Invest; 1970 Dec; 49(12):2222-36. PubMed ID: 5480849 [TBL] [Abstract][Full Text] [Related]
4. Metabolism and excretion of exogenous adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate. Studies in the isolated perfused rat kidney and in the intact rat. Coulson R J Biol Chem; 1976 Aug; 251(16):4958-67. PubMed ID: 182688 [TBL] [Abstract][Full Text] [Related]
5. Effects of sodium nitroprusside on renal functions and NO-cGMP production in anesthetized dogs. Tanahashi M; Sekizawa T; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S J Cardiovasc Pharmacol; 1999 Mar; 33(3):401-8. PubMed ID: 10069675 [TBL] [Abstract][Full Text] [Related]
6. cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3. Beierwaltes WH Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1376-81. PubMed ID: 16449359 [TBL] [Abstract][Full Text] [Related]
7. Renal effects of adenosine 3',5'-cyclic monophosphate and dibutyryl adenosine 3',5'-cyclic monophosphate. Evidence for a role for adenosine 3',5'-cyclic monophosphate in the regulation of proximal tubular sodium reabsorption. Gill JR; Casper AG J Clin Invest; 1971 Jun; 50(6):1231-40. PubMed ID: 4326154 [TBL] [Abstract][Full Text] [Related]
8. Effects of rolipram and cilostamide on renal functions and cyclic AMP release in anesthetized dogs. Tanahashi M; Hara S; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S J Pharmacol Exp Ther; 1999 Jun; 289(3):1533-8. PubMed ID: 10336549 [TBL] [Abstract][Full Text] [Related]
9. 2',3'-cGMP exists in vivo and comprises a 2',3'-cGMP-guanosine pathway. Jackson EK; Mi Z; Janesko-Feldman K; Jackson TC; Kochanek PM Am J Physiol Regul Integr Comp Physiol; 2019 Jun; 316(6):R783-R790. PubMed ID: 30789788 [TBL] [Abstract][Full Text] [Related]
10. Renal and systemic effects of synthetic atrial natriuretic factor. Seymour AA; Blaine EH; Mazack EK; Smith SG; Stabilito II; Haley AB; Napier MA; Whinnery MA; Nutt RF Life Sci; 1985 Jan; 36(1):33-44. PubMed ID: 2981380 [TBL] [Abstract][Full Text] [Related]
11. Elevated plasma and urinary guanosine 3':5'-monophosphate and increased production rate in patients with neoplastic diseases. Chawla RK; Shlaer SM; Lawson DH; Murray TG; Schmidt F; Shoji M; Nixon DW; Richmond A; Rudman D Cancer Res; 1980 Nov; 40(11):3915-20. PubMed ID: 6258769 [TBL] [Abstract][Full Text] [Related]
12. Effects of acetazolamide and changes of acid-base balance on the content of cyclic nucleotides in the rat kidney. Osswald H; Hawlina A Pharmacology; 1979; 19(1):44-50. PubMed ID: 229499 [TBL] [Abstract][Full Text] [Related]
13. [Cyclic nucleotides (cAMP and cGMP) in the dog plasma during extracorporeal hemocarboperfusion]. Koterov AN; Nikol'skiĭ AV; Romantsev EF; Vernigorova LA Biull Eksp Biol Med; 1982 Sep; 94(9):45-7. PubMed ID: 6293619 [TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate in malignancy. Gennari C; Francini G; Galli M; Lore F J Clin Pathol; 1978 Aug; 31(8):735-41. PubMed ID: 211147 [TBL] [Abstract][Full Text] [Related]
15. Effect of salmon calcitonin on renal excretion of adenosine 3', 5' monophosphate in man. Ardaillou R; Isaac R; Nivez MP; Kuhn JM; Cazor JL; Fillastre JP Horm Metab Res; 1976 Mar; 8(2):136-40. PubMed ID: 177347 [TBL] [Abstract][Full Text] [Related]
16. Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats. Conrad KP; Vernier KA Am J Physiol; 1989 Oct; 257(4 Pt 2):R847-53. PubMed ID: 2552845 [TBL] [Abstract][Full Text] [Related]
17. Effect of adrenomedullin on renal hemodynamics and functions in dogs. Ebara T; Miura K; Okumura M; Matsuura T; Kim S; Yukimura T; Iwao H Eur J Pharmacol; 1994 Sep; 263(1-2):69-73. PubMed ID: 7821363 [TBL] [Abstract][Full Text] [Related]
18. Modulation of cyclic nucleotides in islated rat glomeruli: role of histamine, carbamylcholine, parathyroid hormone, and angiotensin-II. Torres VE; Northrup TE; Edwards RM; Shah SV; Dousa TP J Clin Invest; 1978 Dec; 62(6):1334-43. PubMed ID: 219028 [TBL] [Abstract][Full Text] [Related]
19. Hyperkalemia, hyperglycemia, and plasma levels of cyclic AMP and cyclic GMP induced by portal vein injection of cyclic nucleotides and their butyryl derivatives into dogs. Nakashima T; Morita N; Nakanishi Y; Inoki M; Kurogochi Y Can J Physiol Pharmacol; 1982 Dec; 60(12):1584-91. PubMed ID: 6299491 [TBL] [Abstract][Full Text] [Related]
20. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure. Chen HH; Huntley BK; Schirger JA; Cataliotti A; Burnett JC J Am Soc Nephrol; 2006 Oct; 17(10):2742-7. PubMed ID: 16928803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]